Andrew E. Scott

Andrew E. Scott

Auto-generated profile, based on publicly available information

Andrew E. Scott

Defence Science and Technology Laboratory, Porton Down, Salisbury, United Kingdom

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2005 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
PDF file
Catherine Loc-CarrilloCatherine Loc-Carrillo
Catherine Loc-Carrillo
RARobert Atterbury
Robert Atterbury
AEA. El-Shibiny
A. El-Shibiny
PCP. L. Connerton
P. L. Connerton
EDE. Dillon
E. Dillon
Ian ConnertonIan Connerton
Ian Connerton
Colonization of broiler chickens by the enteric pathogen Campylobacter jejuni is widespread and difficult to prevent. Bacteriophage therapy is one possible means by which this colonization could be controlled, thus limiting the entry of campylobacters into the human food chain. Prior to evaluating the efficacy of phage therapy, experimental models of Campylobacter colonization of broiler chickens were established by using low-passage C. jejuni isolates HPC5 and GIIC8 from United Kingdom broiler flocks. The screening of 53 lytic bacteriophage isolates against a panel of 50 Campylobacter isolates from broiler chickens and 80 strains isolated after human infection identified two phage candidates with broad host lysis. These phages, CP8 and CP34, were orally administered in antacid suspension, at different dosages, to 25-day-old broiler chickens experimentally colonized with the C. jejuni broiler isolates. Phage treatment of C. jejuni -colonized birds resulted in Campylobacter counts falling between 0.5 and 5 log 10 CFU/g of cecal contents compared to untreated controls over a 5-day period postadministration. These reductions were dependent on the phage- Campylobacter combination, the dose of phage applied, and the time elapsed after administration. Campylobacter s resistant to bacteriophage infection were recovered from phage-treated chickens at a frequency of <4%. These resistant types were compromised in their ability to colonize experimental chickens and rapidly reverted to a phage-sensitive phenotype in vivo. The selection of appropriate phage and their dose optimization are key elements for the success of phage therapy to reduce campylobacters in broiler chickens.

1 April 2009 in Journal of Food Protection
Verified
Journal Article
Closed access
AEAyman El-Shibiny
Ayman El-Shibiny
ASAndrew Scott
Andrew Scott
ATAndrew Timms
Andrew Timms
YMYasser Metawea
Yasser Metawea
PCPhillippa Connerton
Phillippa Connerton
Ian ConnertonIan Connerton
Ian Connerton
Members of the genus Campylobacter are frequently responsible for human enteric disease worldwide. Persistent Campylobacter contamination of poultry meat is a common problem that represents a signi...

24 August 2007 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
ASAndrew E Scott
Andrew E Scott
ATAndrew R Timms
Andrew R Timms
PCPhillippa L Connerton
Phillippa L Connerton
Catherine Loc-CarrilloCatherine Loc-Carrillo
Catherine Loc-Carrillo
KRKhairul Adzfa Radzum
Khairul Adzfa Radzum
Ian ConnertonIan Connerton
Ian Connerton
Campylobacter jejuni is a leading cause of food-borne illness. Although a natural reservoir of the pathogen is domestic poultry, the degree of genomic diversity exhibited by the species limits the application of epidemiological methods to trace specific infection sources. Bacteriophage predation is a common burden placed upon C. jejuni populations in the avian gut, and we show that amongst C. jejuni that survive bacteriophage predation in broiler chickens are bacteriophage-resistant types that display clear evidence of genomic rearrangements. These rearrangements were identified as intra-genomic inversions between Mu-like prophage DNA sequences to invert genomic segments up to 590 kb in size, the equivalent of one-third of the genome. The resulting strains exhibit three clear phenotypes: resistance to infection by virulent bacteriophage, inefficient colonisation of the broiler chicken intestine, and the production of infectious bacteriophage CampMu. These genotypes were recovered from chickens in the presence of virulent bacteriophage but not in vitro. Reintroduction of these strains into chickens in the absence of bacteriophage results in further genomic rearrangements at the same locations, leading to reversion to bacteriophage sensitivity and colonisation proficiency. These findings indicate a previously unsuspected method by which C. jejuni can generate genomic diversity associated with selective phenotypes. Genomic instability of C. jejuni in the avian gut has been adopted as a mechanism to temporarily survive bacteriophage predation and subsequent competition for resources, and would suggest that C. jejuni exists in vivo as families of related meta-genomes generated to survive local environmental pressures. Campylobacter jejuni is the major cause of bacterial food-borne illness worldwide. Predation of C. jejuni by virulent bacteriophage offers the prospect of controlling bacterial populations at source in poultry. We report that in chickens, bacteriophage resistance is infrequent because the mutants that escape bacteriophage are not proficient in poultry colonisation but readily revert back to colonisation-proficient phage-sensitive types. Bacteriophage resistance is generated by reversible genomic scale inversions, leading to the activation of an unrelated bacteriophage integrated into the bacterial genome. These data not only suggest that bacteriophage therapy of C. jejuni would remain a sustainable measure to reduce poultry contamination but also demonstrate how bacterial genomes can evolve under the strong and widespread pressure of bacteriophage predation in the environment.

1 July 2004 in Applied and Environmental Microbiology
Verified
Journal Article
Open access
PDF file
PCP. L. Connerton
P. L. Connerton
Catherine Loc-CarrilloCatherine Loc-Carrillo
Catherine Loc-Carrillo
CSC. Swift
C. Swift
EDE. Dillon
E. Dillon
ASA. Scott
A. Scott
Ian ConnertonIan Connerton
Ian Connerton
A longitudinal study of bacteriophages and their hosts was carried out at a broiler house that had been identified as having a population of Campylobacter -specific bacteriophages. Cloacal and excreta samples were collected from three successive broiler flocks reared in the same barn. Campylobacter jejuni was isolated from each flock, whereas bacteriophages could be isolated from flocks 1 and 2 but were not isolated from flock 3. The bacteriophages isolated from flocks 1 and 2 were closely related to each other in terms of host range, morphology, genome size, and genetic content. All Campylobacter isolates from flock 1 were genotypically indistinguishable by pulsed-field gel electrophoresis (PFGE). PFGE and multilocus sequence typing indicated that this C. jejuni type was maintained from flock 1 to flock 2 but was largely superseded by three genetically distinct C. jejuni types insensitive to the resident bacteriophages. All isolates from the third batch of birds were insensitive to bacteriophages and genotypically distinct. These results are significant because this is the first study of an environmental population of C. jejuni bacteriophages and their influence on the Campylobacter populations of broiler house chickens. The role of developing bacteriophage resistance was investigated as this is a possible obstacle to the use of bacteriophage therapy to reduce the numbers of campylobacters in chickens. In this broiler house succession was largely due to incursion of new genotypes rather than to de novo development of resistance.

1 August 2014 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
ASAndrew E. Scott
Andrew E. Scott
MBMary N. Burtnick
Mary N. Burtnick
MSMargaret G. M. Stokes
Margaret G. M. Stokes
AWAdam O. Whelan
Adam O. Whelan
EWE. Diane Williamson
E. Diane Williamson
PBPaul J. Brett
Paul J. Brett
Burkholderia pseudomallei, the etiologic agent of melioidosis, is a CDC tier 1 select agent that causes severe disease in both humans and animals. Diagnosis and treatment of melioidosis can be challenging, and in the absence of optimal chemotherapeutic intervention, acute disease is frequently fatal. Melioidosis is an emerging infectious disease for which there are currently no licensed vaccines. Due to the potential malicious use ofB. pseudomalleias well as its impact on public health in regions where the disease is endemic, there is significant interest in developing vaccines for immunization against this disease. In the present study, type A O-polysaccharide (OPS) andmanno-heptose capsular polysaccharide (CPS) antigens were isolated from nonpathogenic, select-agent-excluded strains ofB. pseudomalleiand covalently linked to carrier proteins. By using these conjugates (OPS2B1 and CPS2B1, respectively), it was shown that although high-titer IgG responses against the OPS or CPS component of the glycoconjugates could be raised in BALB/c mice, only those animals immunized with CPS2B1 were protected against intraperitoneal challenge withB. pseudomallei. Extending upon these studies, it was also demonstrated that when the mice were immunized with a combination of CPS2B1 and recombinantB. pseudomalleiLolC, rather than with CPS2B1 or LolC individually, they exhibited higher survival rates when challenged with a lethal dose ofB. pseudomallei. Collectively, these results suggest that CPS-based glycoconjugates are promising candidates for the development of subunit vaccines for immunization against melioidosis.

1 March 2012 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
JCJon Cuccui
Jon Cuccui
TMTimothy S. Milne
Timothy S. Milne
NHNicholas Harmer
Nicholas Harmer
AGAlison J. George
Alison J. George
SHSarah V. Harding
Sarah V. Harding
JPJoann L. Prior
Joann L. Prior
Burkholderia pseudomallei is the causative agent of melioidosis, a disease endemic to regions of Southeast Asia and Northern Australia. Both humans and a range of other animal species are susceptible to melioidosis, and the production of a group 3 polysaccharide capsule in B. pseudomallei is essential for virulence. B. pseudomallei capsular polysaccharide (CPS) I comprises unbranched manno -heptopyranose residues and is encoded by a 34.5-kb locus on chromosome 1. Despite the importance of this locus, the role of all of the genes within this region is unclear. We inactivated 18 of these genes and analyzed their phenotype using Western blotting and immunofluorescence staining. Furthermore, by combining this approach with bioinformatic analysis, we were able to develop a model for CPS I biosynthesis and export. We report that inactivating gmhA , wcbJ , and wcbN in B. pseudomallei K96243 retains the immunogenic integrity of the polysaccharide despite causing attenuation in the BALB/c murine infection model. Mice immunized with the B. pseudomallei K96243 mutants lacking a functional copy of either gmhA or wcbJ were afforded significant levels of protection against a wild-type B. pseudomallei K96243 challenge.